NCT06871605 Transversalis Fascia Plane vs Ilioinguinal and Iliohypogastric Nerve Block for the Treatment of CPIP
| NCT ID | NCT06871605 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Diskapi Teaching and Research Hospital |
| Condition | Inguinal Hernia |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-02-11 |
| Primary Completion | 2025-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-02-11 with a primary completion date of 2025-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study was to compare the efficacy of ultrasound (US)-guided transversalis fascia plane block (TFP) and ilioinguinal (II) and iliohypogastric (IH) nerve block in the treatment of chronic post-herniorrhaphy inguinal pain (CPIP) refractory to conservative treatments. For this evaluation, a numerical rating scale (NRS) will be used before and after both interventions.
Eligibility Criteria
Inclusion Criteria: * Complaints of inguinal pain \>12 weeks post-herniorrhaphy surgery * \>18 years of age * Failure of conservative pain management Exclusion Criteria: * Other causes of inguinal pain (haematoma, infection, tubo-ovarian disease, abscess, etc., gynaecological, urological and organic pathologies after inguinal hernia, etc.) * Pregnancy * Coagulopathy, antiaggregant/anticoagulant/antiplatelet use * Unstable psychiatric illness
Contact & Investigator
Gevher Rabia Genc Perdecioğlu
STUDY CHAIR
Diskapi TRH
Frequently Asked Questions
Who can join the NCT06871605 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Inguinal Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06871605 currently recruiting?
Yes, NCT06871605 is actively recruiting participants. Contact the research team at gozde.canakli@gmail.com for enrollment information.
Where is the NCT06871605 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06871605 clinical trial?
NCT06871605 is sponsored by Diskapi Teaching and Research Hospital. The principal investigator is Gevher Rabia Genc Perdecioğlu at Diskapi TRH. The trial plans to enroll 80 participants.